本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Seres Therapeutics, Inc.

4.21
-0.3900-8.48%
盤後4.210.00000.00%19:30 EDT
成交量:8.38萬
成交額:36.71萬
市值:4,228.86萬
市盈率:-1.74
高:4.84
開:4.55
低:4.18
收:4.60
52周最高:29.98
52周最低:4.18
股本:1,004.48萬
流通股本:883.47萬
量比:2.00
換手率:0.95%
股息:- -
股息率:- -
每股收益(TTM):-2.4137
每股收益(LYR):0.6400
淨資產收益率:-66.57%
總資產收益率:-39.85%
市淨率:1.22
市盈率(LYR):6.58

資料載入中...

2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/20

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/17

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/14

重要事件披露

8-K - Current report
2020/08/13

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/13

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

重要事件披露

8-K - Current report
2020/07/28

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]